
|Articles|August 13, 2008
Viread now also approved to treat hepatitis B
The drug is administered as a once-daily tablet.
Advertisement
The anti-HIV drug Viread (tenofovir disoproxil fumarate, Gilead Sciences) has gained a new indication: to treat chronic hepatitis B in adults. Administered as a once-daily tablet, the
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Wicked Good Cardiometabolic Chat: Identifying and Managing MASH
2
Optimizing MTM Services for Patients With Cardiometabolic Conditions: A Practical Guide for Pharmacists
3
Study Links Antipsychotic Use to Rapid Rise in Youth Type 2 Diabetes
4
Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits
5






















